Skip to main content

Kenneth L. Schaecher, MD, FACP, CPC

Associate Chief Medical Officer, University of Utah Health Plans
Attending Physician - Internal Medicine, Granger Medical Clinic
Salt Lake City, UT

SelectHealth
Salt Lake City, UT

Authored Items
A Payer’s Perspective on CDK4/6 Inhibitors
Kenneth L. Schaecher, MD, FACP, CPC
March 2018, Supplement - Abemaciclib (Verzenio™), a Novel CDK4/6 Inhibitor, in the Treatment of Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer in Perspectives
Conquering COPD: Value-Based Perspectives for Providers and Payers
Jill Ohar, MD, Kenneth L. Schaecher, MD, FACP, CPC, John A. Welz, MPH
Supplements
Last modified: April 9, 2018